CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-10 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +8,109 | 8,109 | ||
| 2021-06-10 | Ballaron Craig Director | Grant or award · Stock Option (right to buy) | +5,834 | 5,834 | ||
| 2021-06-10 | PRYGOCKI MARK A SR Director | Grant or award · Stock Option (right to buy) | +5,834 | 5,834 | ||
| 2021-06-10 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +5,834 | 5,834 | ||
| 2021-06-10 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +5,834 | 5,834 | ||
| 2021-06-04 | White Ted President and CEO | Purchase | +4,000 | $9.95 | $40K | 21,966 |
| 2021-06-04 | Hayes Christopher G. Chief Legal Officer | Purchase | +2,500 | $9.79 | $24K | 2,500 |
| 2021-06-04 | DAVIS A BRIAN Chief Financial Officer | Purchase | +5,000 | $9.89 | $49K | 12,900 |
| 2021-03-25 | Manning Paul B Director | Purchase | +739,830 | $14.75 | $10.9M | 739,830 |
| 2021-03-01 | White Ted President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-03-01 | DAVIS A BRIAN Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2021-03-01 | Goldenberg Gary Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2021-03-01 | Bonaccorso Joe Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2021-03-01 | Hayes Christopher G. Chief Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-08-25 | Ballaron Craig Director | Purchase | +4,772 | $8.57 | $41K | 10,000 |
| 2020-08-24 | Ballaron Craig Director | Purchase | +5,228 | $9.16 | $48K | 5,228 |
| 2020-08-20 | Manning Paul B Director | Purchase | +20,000 | $9.09 | $182K | 8,099,394 |
| 2020-08-18 | Manning Paul B Director | Purchase | +10,000 | $8.55 | $86K | 1,481,719 |
| 2020-08-17 | Manning Paul B Director | Purchase | +6,000 | $6.92 | $42K | 1,471,719 |
| 2020-08-14 | Stalfort Sean Director | Purchase | +15,700 | $6.38 | $100K | 462,110 |
Page 9 of 19 · 372 trades